- Rabeprazole
-
- $6.00 / 10G/Bag
-
2024-04-10
- CAS:117976-89-3
- Min. Order: 1G/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
- Rabeprazole
-
- $0.00 / 1KG
-
2021-11-03
- CAS:117976-89-3
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 500kg
- Rabeprazole USP/EP/BP
-
- $1.10 / 1g
-
2021-07-31
- CAS:117976-89-3
- Min. Order: 1g
- Purity: 0.999
- Supply Ability: 100 Tons min
|
| | Rabeprazole Basic information |
| Product Name: | Rabeprazole | | Synonyms: | 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfinyl]-1h-benzoimidazole;2-[[(3-METHYL-4-(3-METHOXYPROPOXY)-2-PYRIDINYL)METHYL]SULPHINYL]-1H-BENZIMIDAZOLE;2-(CHOLROMETHYL)-4-(3-METHOXYPROPOXY)-3-METHYLPYRIDINE;ly-307640;1H-Benzimidazole,2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-;1H-1,3-benzimidazol-2-yl [4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl sulfoxide-sodium salt;2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;2-[[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole | | CAS: | 117976-89-3 | | MF: | C18H21N3O3S | | MW: | 359.44 | | EINECS: | 601-501-2 | | Product Categories: | Rabeprazole;API's;Active Pharmaceutical Ingredients;APIs | | Mol File: | 117976-89-3.mol |  |
| | Rabeprazole Chemical Properties |
| Melting point | 99-100° (dec) | | Boiling point | 603.9±65.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | Inert atmosphere,Store in freezer, under -20°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 9.57±0.10(Predicted) | | color | Light Brown to Very Dark Brown | | BCS Class | 1,3 | | Stability: | Hygroscopic | | CAS DataBase Reference | 117976-89-3(CAS DataBase Reference) |
| | Rabeprazole Usage And Synthesis |
| Description | Rabeprazole, a proton pump inhibitor (PPI), effectively lowers stomach acid production to alleviate conditions such as gastroesophageal reflux disease (GERD), ulcers, and other issues caused by excessive acid production. It belongs to the benzimidazole derivative family, sharing a structural similarity with omeprazole, another PPI. Rabeprazole hampers the activity of the gastric proton pump responsible for acid production. By binding to the pump, it obstructs the release of hydrogen ions into the stomach, ultimately reducing acid production. Furthermore, rabeprazole exhibits various biochemical and physiological effects. A study conducted on rats revealed that rabeprazole effectively decreases the gastric proton pump′s activity, leading to a decrease in gastric acid secretion. | | Uses | Rabeprazole is used to treat hyperacidity. It is a proton pump inhibitor that helps heal gastrointestinal ulcers, treats gastroesophageal reflux disease, and also treats hypersecretory disorders. | | Definition | ChEBI: Rabeprazole is a member of benzimidazoles, a sulfoxide and a member of pyridines. It has a role as an EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor and an anti-ulcer drug. It is a conjugate acid of a rabeprazole(1-). | | Brand name | Aciphex (Eisai Medical Research)
. | | Side effects | The more common side effects of rabeprazole can include: headache. pain in the abdomen (stomach area) sore throat.
The serious side effects of rabeprazole can include: has stomach cramps, bloated feeling, watery and severe diarrhea which may also be bloody sometimes, fever, nausea or vomiting, or unusual tiredness or weakness. This medicine may increase your risk of having fractures of the hip, wrist, and spine. | | Dosage | Rabeprazole is usually taken once a day. Follow all directions on the prescription label and read all dosing instructions or instruction sheets. Use the medication exactly as directed.Rabeprazole is only suitable for short-term use, usually 4 to 8 weeks. If you need additional treatment time, your doctor may recommend a second course of treatment. |
| | Rabeprazole Preparation Products And Raw materials |
|